Log In

Term Description

This is a single-item, three-part measure taken from the Growing Up Today Study (GUTS) that assesses use and frequency of various products (e.g., creatine, growth hormone, steroids) to improve muscle mass or strength in the past year.

Reference Information

TypeSourceReference
CitationConsensus measures for Phenotypes and ExposuresGrowing Up Today Study (GUTS) GUTS Survey

Panel Hierarchy

Details for each LOINC in Panel LHC-Forms

LOINCNameR/O/CCardinalityExample UCUM Units
94451-2PhenX - Use of Creatine Growth Hormone and Steroids Protocol 230801
Indent90731-1In the past year, how often did you use creatine to improve muscle mass or strength?
Indent90732-9In the past year, how often did you use DHEA, androstenedione, or human growth hormone to improve muscle mass or strength?
Indent90733-7In the past year, how often did you use anabolic steroids to improve muscle mass or strength?

LOINC Names Get Info

Fully-Specified Name
PhenX - Use of creatine growth hormone and steroids protocol 230801:-:Pt:^Patient:-:PhenX
Long Common Name
PhenX - Use of Creatine Growth Hormone and Steroids Protocol 230801
Short Name
PhenX - Creatine GH+steroids use proto

Part Model Get Info

  • Component
    PhenX - Use of creatine growth hormone and steroids protocol 230801
    LP417620-4
    • Analyte
      PhenX - Use of creatine growth hormone and steroids protocol 230801
      LP417620-4
      • Component Numerator
        PhenX - Use of creatine growth hormone and steroids protocol 230801
        LP417620-4
        • Component Numerator Core
          PhenX - Use of creatine growth hormone and steroids protocol 230801
          LP417620-4
        • Component Numerator Core Suffix
          NULL
           
      • Component Denominator
        NULL
         
        • Component Denominator Core
          NULL
           
        • Component Denominator Core Suffix
          NULL
           
    • Challenge
      NULL
       
    • Adjustment
      NULL
       
    • Count
      NULL
       
  • Property
    -
    LP6769-6
  • Time
    Pt
    LP6960-1
  • System
    ^Patient
    LP310005-6
    • System Core
      NULL
       
    • Super System
      Patient
      LP6985-8
  • Scale
    -
    LP7747-1
  • Method
    PhenX
    LP95333-8

Basic Attributes

Class
PANEL.PHENX
Type
Clinical
First Released
Version 2.68
Last Updated
Version 2.68 (ADD)
Order vs. Observation
Both
Panel Type
Panel

Language Variants Get Info

TagLanguageTranslation
el-GRGreek (Greece)PhenX - Χρήση κρεατίνης, αυξητικής ορμόνης και στεροειδών, πρωτόκολλο 230801:-:Pt:^Ασθενής:-:PhenX
Synonyms: - PANEL.PHENX PHENX PhenX - Χρήση κρεατίνης, αυξητικής ορμόνης και στεροειδών, πρωτόκολλο 230801 Pt Ασθενής Κρεατίνη
es-MXSpanish (Mexico)PhenX - Protocolo de uso de la hormona del crecimiento con creatina y esteroides 230801:-:Punto temporal:^ Paciente:-:PhenX
it-ITItalian (Italy)PhenX - Uso dell'ormone della crescita della creatina e degli steroidi, protocollo:-:Pt:^Paziente:-:PhenX
Synonyms: Panel PhenX paziente PhenX Punto nel tempo (episodio)
zh-CNChinese (China)PhenX - 肌酸生长激素和类固醇使用方案 230801:-:时间点:^患者:-:PhenX
Synonyms: Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Consensus measures for Phenotypes and eXposures;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 Cr;甲胍;甲胍基乙酸;甲胍基醋酸;肌氨酸 PhenX - 肌酸生长激素和类固醇（甾类化合物、类固醇激素、类固醇类药物）使用方案 230801;Consensus measures for Phenotypes and eXposures;PhenX;暴露;接触;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标 医嘱套餐 医嘱套餐类 医嘱套餐组 医嘱组 医嘱组.PhenX;组套（组合、医嘱组、套餐、套餐医嘱、医嘱套餐、组合申请、组合项目）.PhenX;Consensus measures for Phenotypes and eXposures;PhenX;表型与暴露共识指标;表现型与暴露共识指标;表型与暴露公认指标;PhenX 医嘱组 医嘱组合 医嘱组合类 医嘱组套 医嘱组套类 医嘱组类 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 多重;多重型;多重标尺类型;多重精度类型 套餐 套餐医嘱 套餐医嘱组 套餐医嘱组类 实验室医嘱套餐 实验室医嘱套餐类 实验室医嘱组 实验室医嘱组合类 实验室医嘱组套 实验室医嘱组套类 实验室套餐医嘱组 实验室套餐医嘱组类 实验室检验项目医嘱组合类 实验室检验项目组合类 时刻;随机;随意;瞬间 检验医嘱组合类 检验项目医嘱组合类 检验项目组合类 甾族化合物 甾族化合物类 类固醇类 组 组合 组合医嘱 组合类 组套 荷尔蒙

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=94451-2
Questionnaire definition
https://fhir.loinc.org/Questionnaire/?url=http://loinc.org/q/94451-2